Search
News & Events
What is neurodiversity?In this blog, Speech Pathologist Emma Corry explores what neurodiversity is, and what it means in the context of supporting autistic children. Many people may have heard the term “neurodiversity” but what does this term actually mean? In this blog, we are going to dive into the foundations of neurodiversity.
News & Events
Communicate your wayTo kick off Speech Pathology Week 2024, we asked our clients, their families and the community to share the different ways they communicate. Senior Speech Pathologist Sally Grauaug compiled their ideas and feedback into this blog.
Our award-winning 60 Second Science video series translates the latest research into an accessible format for the community. Here you will also find our Autism Seminar Series and videos about our clinical services and current research projects.
CliniKids has developed a range of fact sheets to support everyday activities at home. We've also included links to some resources and websites for parents and carers developed by other support services.
Learn more about the SenseVest Study at CliniKids
Research
Infectious complications and optimising infection prevention for children with cochlear implantsTo describe the clinical epidemiology of children receiving cochlear implants, as well as the management and outcomes of cochlear implant infections and adherence to infection prevention measures.
Research
Common and Rare Genetic Variants That Could Contribute to Severe Otitis Media in an Australian Aboriginal PopulationOur goal was to identify genetic risk factors for severe otitis media (OM) in Aboriginal Australians.
Research
LUMOS - Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot studyIntroduction Grades 2 and 3 gliomas (G2/3 gliomas), when combined, are the second largest group of malignant brain tumours in adults. The outcomes for G2/3 gliomas at progression approach the dismal outcomes for glioblastoma (GBM), yet there is a paucity of trials for Australian patients with relapsed G2/3 gliomas compared with patients with GBM.
Research
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrumLarge-scale molecular profiling studies in recent years have shown that central nervous system (CNS) tumors display a much greater heterogeneity in terms of molecularly distinct entities, cellular origins and genetic drivers than anticipated from histological assessment.
Research
Consensus guidelines for improving patients' understanding of invasive fungal disease and related risk prevention in the haematology/oncology setting, 2021Patients with invasive fungal disease (IFD) are at significant risk of morbidity and mortality. A productive partnership between patients, their carers/families, and the multidisciplinary team managing the infection and any underlying conditions, is essential.